Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.
about
Diet and psoriasis: experimental data and clinical evidence.Venous thrombosis and prothrombotic factors in inflammatory bowel disease.Drugs to Treat Systemic Lupus Erythematosus: Relationship between Current Use and Cardiovascular Risk Factors.Identification and characterization of an inborn error of metabolism caused by dihydrofolate reductase deficiencyMethotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR geneDisease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study.Methotrexate modulates the kinetics of adenosine in humans in vivo.Homocysteine and lipid profile in children with Juvenile Idiopathic Arthritis.Pharmacogenetics of methotrexate.Therapeutic potential of folic acid supplementation for cardiovascular disease prevention through homocysteine lowering and blockade in rheumatoid arthritis patients.Rheumatoid disease and the heart: from epidemiology to echocardiography.Pancytopenia after low dose methotrexate therapy in a hemodialysis patient: case report and review of literature.Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelinesVascular and cellular stress in inflammatory bowel disease: revisiting the role of homocysteine.Effects of Methotrexate in a Rabbit Model of In-Stent Neoatherosclerosis: An Optical Coherence Tomography Study.Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival.The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.Lack of cardiovascular risk assessment in inflammatory arthritis and systemic lupus erythematosus patients at a tertiary care center.The effect of folate supplementation on methotrexate efficacy and toxicity in psoriasis patients and folic acid use by dermatologists in the USA.Cardiovascular comorbidity in rheumatic diseases.Cardiovascular risk in patients with rheumatoid arthritis.Causes of DMARD withdrawal following ADR within 6 months of initiation among Indian rheumatoid arthritis patients.Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis with or without psoriatic arthritis: a nationwide cohort study.Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.Plasma total homocysteine level and methylenetetrahydrofolate reductase 677C>T genetic polymorphism in Japanese patients with rheumatoid arthritis.Bone marrow and adipose mesenchymal stem cells attenuate cardiac fibrosis induced by methotrexate in rats.677C>T and 1298A>C MTHFR polymorphisms affect methotrexate treatment outcome in rheumatoid arthritis.Folate deficiency in north Indian children undergoing maintenance chemotherapy for acute lymphoblastic leukemia-Implications and outcome.Prevention of stroke in rheumatoid arthritis.Methotrexate toxicity and efficacy during the consolidation phase in paediatric acute lymphoblastic leukaemia and MTHFR polymorphisms as pharmacogenetic determinants.
P2860
Q31006990-DAB72918-757B-4D25-94E4-C2CDB78AFF0BQ33564092-5623977C-C6CA-4AC4-90E8-899856230519Q33633643-87500A20-873D-4968-B90F-DFBBBF3A4CDDQ34163760-2E8A04A6-1E8C-4C95-89A5-9698F53E3DA9Q35553306-8176CB65-66FD-417B-A162-F332A9A050EDQ35605663-06331E3C-7CDB-4DD3-9E12-9EB0BD448F86Q35636960-D001D52E-0E44-4F7E-BBD2-5EE80235B10DQ35794642-84FC37BC-B1B1-4D98-951D-9145828900CDQ35911142-0CA7D0D5-3672-4723-8623-90770047001BQ36027291-29A9F640-38A7-424E-B234-0F36A48B0847Q36040885-C1947A20-885B-43FB-B26F-0C0BB15DA494Q36417062-956490D9-A147-454C-8EBC-B15FCD0AD84BQ36724093-F35132D1-95C7-4B4A-955C-FAE3E6E65CA5Q36758644-FAF1849B-388D-4559-9C19-7B6C2FD1C1BAQ37267458-B7A6EE03-AAA4-45DF-AE01-B8202F8922D0Q37369929-BF542040-441E-40D2-B134-6AF744BD962AQ37640953-7A555072-4D06-45C2-A603-2027C78AE011Q37866668-59DFD8F4-9E1E-4934-83B7-ED085E664619Q38098061-E9ECAE32-A5C4-40C0-9B2B-724250163419Q38568465-10006973-A7AB-4905-A11C-BEC9A415B9FDQ38813397-ECE64760-ED42-40C9-9B80-FBD4F24B5651Q41934162-88DF05D2-9C58-41A2-AD82-92DA6E9D75C2Q43578147-4B8CFF0C-BC47-4245-BF78-1F539B8261F4Q44621683-29103501-FE6B-421D-B386-7E6844BB46C4Q46090014-A5DBBBC8-0F97-48B7-BCEA-811B9215F107Q46255850-68B3FF68-071D-4F6F-BDFA-FB7D55569385Q46885439-32D2253E-BA51-490D-9875-03E00DD590BDQ48307126-E7D8B69C-B8F3-41FD-A944-9ADAB2D76211Q53502883-7F65F22A-6DDF-45EE-BEB1-10F37FD973A0Q54372512-BB88D962-5C70-4892-8BA5-7067C6D1AD66
P2860
Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Homocysteine and folate status ...... nts with rheumatoid arthritis.
@en
Homocysteine and folate status ...... nts with rheumatoid arthritis.
@nl
type
label
Homocysteine and folate status ...... nts with rheumatoid arthritis.
@en
Homocysteine and folate status ...... nts with rheumatoid arthritis.
@nl
prefLabel
Homocysteine and folate status ...... nts with rheumatoid arthritis.
@en
Homocysteine and folate status ...... nts with rheumatoid arthritis.
@nl
P2093
P2860
P356
P1433
P1476
Homocysteine and folate status ...... nts with rheumatoid arthritis.
@en
P2093
Haagsma CJ
van Ede AE
van de Putte LB
P2860
P304
P356
10.1093/RHEUMATOLOGY/41.6.658
P50
P577
2002-06-01T00:00:00Z